Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000881464-12-000017
Filing Date
2012-08-03
Accepted
2012-08-03 16:25:25
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 amln201263010q.htm 10-Q 1347078
2 AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT amlnexhibit1012012630.htm EX-10.1 18954
3 SIXTH AMENDMENT TO EXENATIDE MANUFACTURING AGREEMENT amlnexhibit1022012630.htm EX-10.2 21595
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER amlnexhibit3112012630.htm EX-31.1 11970
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER amlnexhibit3122012630.htm EX-31.2 13290
6 CERTIFICATIONS PURSUANT TO USC SECTION 1350 amlnexhibit3212012630.htm EX-32.1 8200
  Complete submission text file 0000881464-12-000017.txt   9539899

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT amln-20120630.xml EX-101.INS 1753825
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amln-20120630.xsd EX-101.SCH 61284
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amln-20120630_cal.xml EX-101.CAL 96111
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amln-20120630_def.xml EX-101.DEF 227363
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amln-20120630_lab.xml EX-101.LAB 648514
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amln-20120630_pre.xml EX-101.PRE 360850
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 121007115
SIC: 2834 Pharmaceutical Preparations